Thursday, October 23, 2014

The Evolution of Performance Socks and Compression Sleeves

An Evolution of Socks and Compression Sleeves: From Simple Support to Injury Prevention Socks have always been a critical component to the modern athlete’s wardrobe. Recently the consumer sports medicine marketplace has begun to offer a number of sock designs to help prevent and treat injuries. Back in the late ‘70s, the confluence of the running boom and a robust economy in the '80s inspired sock manufacturers to start thinking about ways to improve sock construction and design. Interest in sock research and development led to advancements in four areas: wicking materials, materials with decreased friction, pressure management and compressive support. Recently, compressive sleeves in the ankle and shin have spun off from the core sock business as additional sock related garments to help with injury prevention and workout recovery. In order to examine the characteristic of sock materials, one must first understand the difference between "hydrophobic," which refers to wicking water through the fiber, and “hydrophilic,” drawing water to the fiber. These terms can be used conjointly when describing the fluid dynamics in socks as some fibers have characteristics of both components. The key is that whatever sweat or moisture is produced needs to be moved away from the foot, whether it is wicked through the fiber or drawn into it. The coefficient of friction increases with moisture on the skin, therefore blisters are more likely to occur on socks that do not provide moisture management. When combining hydrophobic qualities and mechanical fiber qualities, the fibers that wick moisture are, from best to worst: CoolMax®, acrylic, polypropylene, wool, cotton. If you are using high-grade materials, a two-layer system can be more effective with CoolMax®, a polyester fiber, as the outer layer. CoolMax® has its roots in the concept writings of DuPont scientists in the ‘20s. Dacron, a precursor polyester fiber was later modified and renamed CoolMax®, which is unique in its four-layer hydrophilic construction. Acrylic is a material that has good heat retention and hydrophilic properties, only slightly less than CoolMax®. Acrylic is another less costly material used in many wool blends for higher performance and durability. Polypropylene is a cheaper material that is hydrophobic and used in some sports synthetic socks. Nylon, by contrast, is hydrophobic, and normally blocks the moisture. Today, there are moisture treatments that can change the aqueous nature of some fibers, like nylon, making them hydrophilic. Although this can be an expensive process, Polypropylene is a cheaper material more frequently used by manufacturing companies who supply discount sporting goods items. Also, spandex, the fiber used to optimize fit and stretch, is quite critical to sizing. Most higher-end performance or Diabetic sock products will offer multiple sizing as compared to cheaper brands. Wool is one of the oldest natural fibers used in socks and offers excellent wicking properties in product lines such as Smartwool. One of the downsides is that it wears out more easily. Therefore, some companies, like Darn-Tuff, offer lifetime warranties for their combinations. Smartwool extends a performance guarantee but stipulates that reasonable wear will not be covered. Assuming you have a properly fitted shoe, the sock is the first layer of defense against skin injury. There have been attempts to use double-layer socks for anti-blister effect but adding a second layer can generate excess heat, which, in turn, produces more sweat. The problem with accumulating moisture in wet material is that it collapses. This is important with so-called performance socks. The extra friction and shear protection they give requires that the terry padding or layers stay relatively dry. It has been studied and proven by Dr. Richie, et. al., that moisture wicking, properly padded and/or layered socks prevent blistering and skin injury in runners. Doug Richie, DPM, outlined the seminal work of Veve regarding the reduction of pressure with padded socks in his CME paper, in 2008. Thorlo sports socks were studied, along with experimental socks and reductions in pressure were noted in both. Donaghue and others demonstrated durability in pressure management of Thorlo socks. There has been little credible research done on anti-microbial properties in socks. It is generally accepted that these treatments and fibers create a healthier environment for the foot. But, the EPA heavily regulates the technology involved in this process and the standard of proof for benefit is too costly for most companies. Dave Higgins, former president of Thorlo, is the designer of the FS6 Plantar Fasciitis Sleeve and other compression sock brands. He has been in the sock development industry for decades. He and Doug Richie collaborated on diabetic sock development in the early ‘90s and are recognized as inventors of the Diabetic Sock marketplace. Higgins’ current company, ING Source, has partnered with Darco to distribute the FS6 in the Podiatric market. The idea behind the FS6 Plantar Fasciitis Sleeve is to create an orthopedic product that provides both support and pain relief to heel pain and Plantar Fasciitis sufferers. This is achieved by keeping a consistent stretch across fascia. It can also be used to treat Achilles tendonitis and ankle sprains. Introduced in the fall of 2012, it makes up 35% of all orthopedic appliances sold. Since June 2013, the product has been the top-selling orthopedic appliance in running shops across America. At the Running Expo in Austin Texas, it was crowned "New Product of the Year.” Mel Chrestman an outdoor and running sales representative notes that there were almost 20 new sock and orthopedic manufacturers at the Expo. Compression support sleeves and socks are the third innovation that has evolved in the sock industry. Zensah makes a compression leg sleeve geared at athletes for quicker recovery from calf problems and shin splints. Zensah is more fashion forward than most, offering an array of vivid, bright colors. Other brands are also quickly growing in both general health and sports market. The FDA regulates the formula for the compression gradient in compression socks. However, only some companies have chosen to manufacture their products within FDA guidelines. Garments are tested on a CMD100 Compression Tester for compliance to FDA standards. The test equipment is calibrated to the British Standard for medical stockings. This does not mean that non-standardized socks will not work but they may be less effective or, in the worst case, create a tourniquet effect. The FDA also expects companies to abide by approved manufacturing practices. ING Source’s FS6 and its Calf Sleeve, CS6, are both FDA registered and targeted more for medical market use. There has been a trend by runners, most notably marathon champion Paula Radcliffe, to wear performance compression socks and sleeves. Pro teams including the NFL also use compressive performance socks. Matt Werd, DPM, a seasoned Ironman Triathlete and past president of the American Academy of Podiatric Sports Medicine, notes that about 1 in 10 triathletes use some form of compression sleeve or sock. He occasionally uses compression socks in training but generally refrains from using them in competition because of the heat created by knee high compression socks, particularly in warmer weather climates. He has tried Herzog, a company based out of the Netherlands. He notes that leg and arm sleeves are frequently used for temperature regulation in endurance training and competition. Sigvaris and CEP are two major manufacturers of performance socks and sleeves. They have recovery socks rated at 15-20mm HG and performance socks rated at 20-30 mm Hg. The research on the efficacy for socks is limited. One small study, by Kemmler et. al., showed increased maximal load with use of the compressive socks. The study conceded that there could have been placebo effect but a pre-questionnaire showed hesitancy to wear compressive socks which would seem to lessen a placebo effect. The evaluation of lactate and lactic acid as an indicator for muscle fatigue in studies is controversial. Kravitz's article summarizes the new thinking:" Lactate production is ACTUALLY A CONSEQUENCE of cellular acidosis and NOT the cause of the acidosis. More blatantly, lactate production actually RETARDS ACIDOSIS. Lactate is a temporary ‘neutralizer’ or ‘buffer’ to the cells elevated accumulation of protons during high-intensity exercise. Since increased lactate production coincides with acidosis, lactate measurement is an excellent ‘indirect’ marker for the metabolic condition of the cell." The development of socks from garments to injury preventative socks and orthopedic sleeves has made the discussion even more relevant for podiatric sports medicine practices. Most sock companies require large inventory to become a vendor. Compression sleeves do not require the same inventory and have less size skews than socks making stocking easier. The medical grade companies have a broader range size skews and many will allow smaller orders as a healthcare provider. These products have become excellent tools for assisting patients perform better and help in injury prevention and recovery. Chrestman, Mel- Interview 2013 Higgins, Dave – Interview 2013 Kemmler, W., von Strengel, S., Kockkritz, C., Mayhew, J., Wassermann, A., & ZapF, J. 2009, “ Effect of compression stockings on running performance in men runners”, Journal of Strength and Conditioning Research, Vol 23, No. 1, pp. 101-105. Naylor PE. Experimental friction blisters. Br J Dermatol. 1955;67:327-335. Parker, Tim _interview 2014 Richie, Jr Douglas H., D.P.M. Socks & Your Feet Socks: Hosiery -Essential Equipment for the Athlete Vercruyssen,F., Easthope, C., Bernard, T., Hausswirth, C., Bleuzen, F., Gruet, M., et al. 2012,“The influence of wearing compression stockings on performance indicators and physiological responses following a prolonged trail running exercise”, European Journal of Sport Science, Vol. 1, pp. 1-7. Werd, Matt, D.P.M. (interview) 2014

Thursday, October 2, 2014

Catching or Crashing on the Wave of New Sports Medicine Technology: PRP and other Cell Therapy

Platelet Rich Plasma (PRP) has its advocates as a viable treatment option, but it lacks evidence shown in clinical studies substantiating these claims. There is very little difference between placebo and treatment groups. The PRP disposable kit costs approximately 250 dollars per kit. Skeletal muscle has a greater regenerative capacity than tendon and ligament. There is also the cost of the centrifuge (approximately 10,000 dollars) needed to spin the blood down. One small level 3 evidence study showed comparable results to cortisone injections for plantar fasciitis after three months using VAS scores. As with lasers, PRP has not yet established strong efficacy for musculoskeletal use. One disadvantage of PRP is that the potency of the cells is dependent on the age of the patient. Stem cell harvesting from adipose tissue and bone marrow may be the next progression in regenerative technologies but there are no large trials to support the theory at this time. Finally, amniotic tissue is being investigated and used for musculoskeletal injuries. Amniotic tissue has the advantage of possessing very young cells, which are pluripotent (able to differentiate into all three germ layers). The price of ¼ cc of tissue ranges from $500-$750. One plantar fascial injection uses ¼ cc. One small study, that had Charles Zelen, DPM as the lead investigator, showed some promise versus control for an eight week follow-up for plantar fasciitis.

Monday, September 29, 2014

Catching or Crashing on the Wave of New Sports Medicine Technology

There are a number of new technologies in the sports medicine space that promise to get you back in the game more quickly. How do you as the patient know what to believe? One important question is “Does the technology provide long term relief”." If the patient has shown noticeable improvement immediately after prescribed treatment but returns to symptoms after activity, they will be left unsatisfied with the treatment. David Armstrong, DPM, MD (University of Arizona) adds that it is difficult to cut through the noise around many technologies. It is expensive to run good quality studies and smaller companies rely on 510k status to cover like technologies. On the other hand, he believes some potential good technologies never see the light of day. The other question to ask is how the natural progression of the acute or chronic injury compares with the improvement noted after intervention. One example is heel pain. Studies have stated that there may be as high as 90% conservative improvement with heel pain. Specialists obviously will get the recalcitrant cases. The argument can be made that continuing a trajectory of failed treatments will cost more money than an intervention that will cure the problem earlier. For example, there are about 1 million patient visits for plantar fasciitis alone in the United States with an estimated cost of $192 million to $376 million dollars. The average time for resolution for plantar fasciitis is about 18 months. Look for part 2 on this topic Thursday.

Monday, September 8, 2014

Brave New World Of Regenerative Medicine

It's a brave new world of regenerative medicine. David Armstrong DPM, MD has a lecture devoted to replacement parts. Another type of regenerative medicine is using cells to repair injuries. With appropriate cell signaling organs can be created from cells. Amnion cells are being used to help heal injuries. They are more potent than stem cells derived from our own bodies because they are not worn down with age. Industry studies, including one with Dr. James Andrews as a secondary author, that are double blinded have shown some promise injecting these substances into injured area like the ankle and plantar fascia as well as arthritic joints. Dr. Andrews is the consultant orthopedic surgeon to NFl teams with tricky knee injuries like RGIII's. Stay tuned!